News
07-22-2020, 09:17 PM
Diagnostics company SphingoTec GmbH today announced the launch of its IB10 sphingotest bio-ADM, a CE-IVD-marked point-of-care test to quantitatively determine blood levels of Bioactive Adrenomedullin (bio-ADM).
More... (https://www.news-medical.net/news/20200722/SphingoTec-introduces-a-CE-IVD-marked-point-of-care-test-to-determine-blood-levels-of-bio-ADM.aspx)
More... (https://www.news-medical.net/news/20200722/SphingoTec-introduces-a-CE-IVD-marked-point-of-care-test-to-determine-blood-levels-of-bio-ADM.aspx)